Last updated on August 2014

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Type 2 Diabetes Mellitus. THEMIS - effect of Ticagrelor on Health Outcomes in diabetes Mellitus patients Interventional Study


Brief description of study

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Type 2 Diabetes Mellitus. THEMIS - effect of Ticagrelor on Health Outcomes in diabetes Mellitus patients Interventional Study

Detailed Study Description

The purpose of the study is to evaluate whether a new antiplatelet therapy, Brilinta® (Ticagrelor) approved by the FDA, for the reduction of major cardiovascular events in patients with certain heart conditions, is effective in preventing the occurrence of heart attack, stroke and/or death due to cardiovascular events in patients who have Type 2 Diabetes Mellitus and known coronary artery disease.

Clinical Study Identifier: TX139070

Contact Investigators or Research Sites near you

Start Over

Wendy Schneider, MSN, RN, CCRC

Holy Cross Jim Moran Heart and Vascular Research Institute
Coral Springs, FL USA
  Connect »